STEREEN ZEBARI: Open Payments
NPI 1619526407 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 11 payments from 7 companies in 2025. Trend: 2023 $31 · 2024 $0 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $66 |
| Ardelyx, Inc. | 2 | $57 |
| Lilly USA, LLC | 1 | $28 |
| ABBVIE INC. | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
| Gilead Sciences, Inc. | 1 | $22 |
Products named: TREMFYA, ENTYVIO, IBSRELA, OMVOH, MAVYRET, IQIRVO.
Industry payments across AZ — which companies pay providers there.
